Inventor
Guy L. Reed
Inventor
Winchester, MA, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides34%
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
C12NMicroorganisms or enzymes2%
LOC062%
PatentTitleYear
11,078,297Prophylaxis of thrombosis202111,066,482Specific plasmin inactivation by anticatalytic antibody202110,676,539Tissue plasminogen activator antibodies and methods of use202010,160,813Tissue plasminogen activator antibodies and methods of use20189,834,614Method of increasing plasmin activity through antiplasmin conversion20179,150,903'Method of increasing plasmin activity through antiplasmin conversion'20156,750,323'Platelet activation protein'20046,576,431'Antibodies that bind to 2-antiplasmin crosslinked to fibrin which do not inhibit plasma 2-antiplasmin'20036,534,035'Methods of inhibiting clot formation'20036,280,730'Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin'20016,210,667'Bacterial fibrin-dependent plasminogen activator'20016,160,108'Platelet activation protein'20006,114,506'Composition and method for enhancing fibrinolysis'20005,939,540'Platelet secretory transport protein'19995,854,049'Plasmin-resistant streptokinase'19985,831,031'Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin'1998D0397885'Display case for photographs and cards resembling a baseball bat'19985,773,228'Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto'19985,620,688'Methods of inhibiting the activation of Factor XIII'19975,582,862'Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin'19965,470,957'Immunoinhibitors of factor XIII'19955,446,132'Thrombin-activated platelet protein-2 (TAPP-2)'19955,372,812'Composition and method for acceleration of clot lysis'19945,332,665'Species specific, high affinity monoclonal antibodies'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2003Patents assigned to GEN HOSPITAL CORP (11)· patent assignee history
1994–2004Based in Winchester, MA, US· patent location history
1995–2004Patents assigned to HARVARD COLLEGE (8)· patent assignee history
1997–2000Patents assigned to BRISTOL MYERS SQUIBB CO (2)· patent assignee history
2015–2021Patents assigned to TRANSLATIONAL SCIENCES INC (3)· patent assignee history
2015–2021Patents assigned to REED GUY L (2)· patent assignee history
2015–2021Based in Memphis, TN, US· patent location history
2017Based in Memphi, TN, US· patent location history
2018–2020Based in Knoxville, TN, US· patent location history
2021Based in Paradise Valley, AZ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GEN HOSPITAL CORP | 11 | 1994–2003 |
| HARVARD COLLEGE | 8 | 1995–2004 |
| TRANSLATIONAL SCIENCES INC | 3 | 2015–2021 |
| BRISTOL MYERS SQUIBB CO | 2 | 1997–2000 |
| REED GUY Lself | 2 | 2015–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Winchester, Massachusetts, US | 16 | 1994–2004 |
| Memphis, TN, US | 2 | 2015–2021 |
| Knoxville, TN, US | 2 | 2018–2020 |
| Paradise Valley, AZ, US | 1 | 2021 |
| Memphi, TN, US | 1 | 2017 |